Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Ann Surg Oncol. 2017 Jul 12;24(11):3141–3147. doi: 10.1245/s10434-017-5965-5

Fig 1.

Fig 1

Disease-free survival

For calculation of disease-free survival, the occurrence of ipsilateral breast tumor recurrence or contralateral breast cancer (in situ and invasive), regional or distant recurrence, or death attributable to any cause was considered an event.